PL1753427T3 - Zastosowanie podstawionych pochodnych chinoliny do leczenia chorób wywoływanych przez prątki lekooporne - Google Patents

Zastosowanie podstawionych pochodnych chinoliny do leczenia chorób wywoływanych przez prątki lekooporne

Info

Publication number: PL1753427T3
Authority: PL; Poland
Prior art keywords: treatment; drug resistant; quinoline derivatives; substituted quinoline; mycobacterial diseases
Prior art date: 2004-05-28

Application number

PL05743054T

Other languages

English (en)

Inventor

Koenraad Jozef Lodewijk Marcel Andries

Gestel Jozef Frans Elisabetha Van

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-28

Filing date

2005-05-24

Publication date

2008-09-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929150&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1753427(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-05-24 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2008-09-30 Publication of PL1753427T3 publication Critical patent/PL1753427T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Quinoline Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL05743054T 2004-05-28 2005-05-24 Zastosowanie podstawionych pochodnych chinoliny do leczenia chorób wywoływanych przez prątki lekooporne PL1753427T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP04102402		2004-05-28
PCT/EP2005/052371 WO2005117875A1 (en)	2004-05-28	2005-05-24	Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
EP05743054A EP1753427B1 (en)	2004-05-28	2005-05-24	Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases

Publications (1)

Publication Number	Publication Date
PL1753427T3 true PL1753427T3 (pl)	2008-09-30

Family

ID=34929150

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05743054T PL1753427T3 (pl)	2004-05-28	2005-05-24	Zastosowanie podstawionych pochodnych chinoliny do leczenia chorób wywoływanych przez prątki lekooporne

Country Status (34)

Country	Link
US (2)	US20070249667A1 (pl)
EP (1)	EP1753427B1 (pl)
JP (2)	JP5081617B2 (pl)
KR (2)	KR20130024969A (pl)
CN (2)	CN1976704B (pl)
AP (1)	AP2037A (pl)
AR (1)	AR049127A1 (pl)
AT (1)	ATE390925T1 (pl)
AU (1)	AU2005249231B2 (pl)
BR (1)	BRPI0510414B1 (pl)
CA (1)	CA2566544C (pl)
CL (1)	CL2009001980A1 (pl)
CY (1)	CY1110388T1 (pl)
DE (1)	DE602005005810T2 (pl)
DK (1)	DK1753427T3 (pl)
EA (1)	EA010651B1 (pl)
ES (1)	ES2306146T3 (pl)
HR (1)	HRP20080307T3 (pl)
IL (1)	IL179630A (pl)
JO (1)	JO2524B1 (pl)
ME (1)	ME01105B (pl)
MX (1)	MXPA06013888A (pl)
MY (1)	MY140611A (pl)
NO (1)	NO338624B1 (pl)
NZ (1)	NZ550840A (pl)
PA (1)	PA8635201A1 (pl)
PL (1)	PL1753427T3 (pl)
PT (1)	PT1753427E (pl)
RS (1)	RS50585B (pl)
SI (1)	SI1753427T1 (pl)
TW (1)	TWI363625B (pl)
UA (1)	UA90267C2 (pl)
WO (1)	WO2005117875A1 (pl)
ZA (1)	ZA200609899B (pl)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1753427B1 (en) *	2004-05-28	2008-04-02	Janssen Pharmaceutica N.V.	Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
JP2006182755A (ja) *	2004-12-24	2006-07-13	Janssen Pharmaceut Nv	潜伏性結核の処置
EE05697B1 (et) *	2005-06-08	2014-02-17	Janssen Pharmaceutica N.V.	Kinoliini derivaadid kui antibakteriaalsed toimeained
JP5349730B2 (ja) *	2005-06-09	2013-11-20	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	抗バクテリア剤としてのキノリン誘導体
JO3270B1 (ar) *	2005-06-28	2018-09-16	Janssen Pharmaceutica Nv	مشتقات كوينولين بصفة عوامل مضادة للبكتيريا
JO2752B1 (en) *	2005-06-28	2014-03-15	شركة جانسين فارماسوتيكا ان. في	Quinoline derivatives acting as antibacterial agents
DK1898909T3 (en) *	2005-06-28	2017-02-06	Janssen Pharmaceutica Nv	QUINOLIN DERIVATIVES AS ANTIBACTERIAL AGENTS
US8686002B2 (en)	2005-08-21	2014-04-01	AbbVie Deutschland GmbH & Co. KG	Heterocyclic compounds and their use as binding partners for 5-HT5 receptors
UA97813C2 (uk) *	2006-12-05	2012-03-26	Янссен Фармацевтика Н.В.	Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу
JO2683B1 (en) *	2006-12-06	2013-03-03	جانسين فارماسوتيكا ان. في	Quinoline antibacterial derivatives
JO2685B1 (en) *	2006-12-06	2013-03-03	جانسين فارماسوتيكا ان في	Quinoline antibacterial derivatives
JO2725B1 (en) *	2006-12-06	2013-09-15	جانسين فارماسوتيكا ان. في	Quinoline antibacterial derivatives
JO2970B1 (en)	2006-12-06	2016-03-15	جانسين فارماسوتيكا ان. في	Quinoline antibacterial derivatives
JO3271B1 (ar) *	2006-12-06	2018-09-16	Janssen Pharmaceutica Nv	مشتقات الكوينولين المضادة للجراثيم
JO2684B1 (en) *	2006-12-06	2013-03-03	جانسين فارماسوتيكا ان في	Quinoline antibacterial derivatives
MD4009C2 (ro) *	2008-07-15	2010-08-31	Институт Химии Академии Наук Молдовы	Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos
RU2404971C2 (ru) *	2008-12-02	2010-11-27	ЗАО "Фарм-Синтез"	Новые производные хинолина, способ их получения, их применение для лечения микобактериальных инфекций, фармацевтическая композиция на их основе
JP2013504591A (ja) *	2009-09-11	2013-02-07	バーテックスファーマシューティカルズインコーポレイテッド	Ｎ−ベンジル−３−（４−クロロフェニル）−２−［メチル−［２−オキソ−２−（３，４，５−トリメトキシフェニル）アセチル］アミノ］−ｎ−［３−（４−ピリジル）−１−［２−（４−ピリジル）エチル］プロピル］プロパンアミドの組成物およびその使用
CN102249935B (zh)	2010-05-17	2015-05-20	中国人民解放军军事医学科学院毒物药物研究所	芳香2-丁醇类化合物及其医药用途
CN104254527B (zh)	2012-04-27	2017-05-31	詹森药业有限公司	抗菌的喹啉衍生物
AU2013254670B2 (en)	2012-04-27	2017-03-30	Janssen Pharmaceutica Nv	Antibacterial quinoline derivatives
WO2016008381A1 (zh) *	2014-07-14	2016-01-21	辰欣药业股份有限公司	吡啶衍生物及其作为抗分支杆菌的应用
CN105330595B (zh) *	2014-07-14	2019-12-10	上海嘉坦医药科技有限公司	吡啶衍生物及其作为抗分支杆菌的应用
FI3250182T3 (fi)	2015-01-27	2023-06-28	Janssen Pharmaceutica Nv	Dispergoituvia koostumuksia
CN106279017A (zh) *	2015-05-21	2017-01-04	重庆圣华曦药业股份有限公司	贝达喹啉晶型、组合物及其制备方法
RU2018111482A (ru) *	2015-10-20	2019-11-21	Чжэцзян Хисунь Фармасьютикал Ко., Лтд.	Кристаллические формы бедаквилин фумарата и способы их получения
WO2017121323A1 (zh) *	2016-01-13	2017-07-20	辰欣药业股份有限公司	一种吡啶衍生物类化合物的制备方法及其中间体和晶型
CA3016068C (en) *	2016-03-07	2024-02-27	The Global Alliance For Tb Drug Development, Inc.	Antibacterial compounds and uses thereof
CN107243008B (zh) *	2017-04-13	2021-03-30	中国科学院广州生物医药与健康研究院	吡唑并[1,5-a]吡啶类化合物的新应用及一种治疗脓肿分枝杆菌感染的组合物
JP7184260B2 (ja) *	2017-09-01	2022-12-06	学校法人北里研究所	マイコバクテリウム・アビウム複合感染症に対する治療活性を有する新規化合物及びその製造方法
WO2020047596A1 (en) *	2018-09-04	2020-03-12	Monash University	Antibacterial compounds and methods of use
WO2020144197A1 (en)	2019-01-09	2020-07-16	Janssen Pharmaceutica Nv	Combination in the treatment of nontuberculous mycobacterial diseases
US20230348436A1 (en) *	2019-11-26	2023-11-02	Nanyang Technological University	Compounds for treating tuberculosis
CN110804016B (zh) *	2019-12-05	2022-11-04	福建省微生物研究所	抗结核分枝杆菌的二芳基喹啉衍生物
KR20230107275A (ko)	2020-11-12	2023-07-14	얀센 파마슈티카 엔.브이.	비결핵성 마이코박테리아 질환의 치료에서 베다퀼린, 에탐부톨 및 마크롤라이드의 조합물
WO2023217279A1 (zh) *	2022-05-13	2023-11-16	广州嘉越医药科技有限公司	一种吡啶衍生物、中间体、制备方法和应用
WO2023227123A1 (zh) *	2022-05-27	2023-11-30	广州嘉越医药科技有限公司	吡啶衍生物的用途
WO2023232838A1 (en)	2022-05-31	2023-12-07	Janssen Pharmaceutica Nv	Bedaquiline for use in the treatment of leprosy
CN120225518A (zh) *	2022-11-15	2025-06-27	伊莱利利公司	Ahr激动剂
WO2025068448A1 (en)	2023-09-28	2025-04-03	Janssen Pharmaceutica Nv	Atp synthase inhibitors for use in the treatment of non-tuberculosis mycobacteria

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5399558A (en) *	1993-11-24	1995-03-21	Pathogenesis Corporation	Isoflavonoid antibacterial compounds, compositions and use
WO1998018326A1 (en) *	1996-10-28	1998-05-07	Department Of The Army, U.S. Government	Compounds, compositions and methods for treating antibiotic-resistant infections
US6103905A (en) *	1997-06-19	2000-08-15	Sepracor, Inc.	Quinoline-indole antimicrobial agents, uses and compositions related thereto
DK2301544T3 (da) *	2002-07-25	2013-01-02	Janssen Pharmaceutica Nv	Quinolinderivater som mellemprodukter til mykobakterielle inhibitorer
EP1753427B1 (en) *	2004-05-28	2008-04-02	Janssen Pharmaceutica N.V.	Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
EE05697B1 (et) *	2005-06-08	2014-02-17	Janssen Pharmaceutica N.V.	Kinoliini derivaadid kui antibakteriaalsed toimeained

2005
- 2005-05-24 EP EP05743054A patent/EP1753427B1/en not_active Expired - Lifetime
- 2005-05-24 KR KR1020137002606A patent/KR20130024969A/ko not_active Ceased
- 2005-05-24 EA EA200602260A patent/EA010651B1/ru active Protection Beyond IP Right Term
- 2005-05-24 US US11/569,681 patent/US20070249667A1/en not_active Abandoned
- 2005-05-24 BR BRPI0510414-9A patent/BRPI0510414B1/pt not_active IP Right Cessation
- 2005-05-24 HR HR20080307T patent/HRP20080307T3/xx unknown
- 2005-05-24 PL PL05743054T patent/PL1753427T3/pl unknown
- 2005-05-24 PT PT05743054T patent/PT1753427E/pt unknown
- 2005-05-24 UA UAA200611048A patent/UA90267C2/ru unknown
- 2005-05-24 RS RSP-2008/0291A patent/RS50585B/sr unknown
- 2005-05-24 MX MXPA06013888A patent/MXPA06013888A/es active IP Right Grant
- 2005-05-24 NZ NZ550840A patent/NZ550840A/en not_active IP Right Cessation
- 2005-05-24 AT AT05743054T patent/ATE390925T1/de active
- 2005-05-24 JP JP2007513922A patent/JP5081617B2/ja not_active Expired - Lifetime
- 2005-05-24 ME MEP-2008-89A patent/ME01105B/me unknown
- 2005-05-24 SI SI200530294T patent/SI1753427T1/sl unknown
- 2005-05-24 WO PCT/EP2005/052371 patent/WO2005117875A1/en not_active Ceased
- 2005-05-24 DE DE602005005810T patent/DE602005005810T2/de not_active Expired - Lifetime
- 2005-05-24 DK DK05743054T patent/DK1753427T3/da active
- 2005-05-24 CA CA2566544A patent/CA2566544C/en not_active Expired - Lifetime
- 2005-05-24 KR KR1020067024974A patent/KR101371653B1/ko not_active Expired - Lifetime
- 2005-05-24 CN CN2005800170162A patent/CN1976704B/zh not_active Expired - Fee Related
- 2005-05-24 ES ES05743054T patent/ES2306146T3/es not_active Expired - Lifetime
- 2005-05-24 AU AU2005249231A patent/AU2005249231B2/en not_active Expired
- 2005-05-24 AP AP2006003828A patent/AP2037A/xx active
- 2005-05-24 CN CN2012103943126A patent/CN102908347A/zh active Pending
- 2005-05-24 JO JO200574A patent/JO2524B1/en active
- 2005-05-27 PA PA20058635201A patent/PA8635201A1/es unknown
- 2005-05-27 MY MYPI20052432A patent/MY140611A/en unknown
- 2005-05-27 AR ARP050102200A patent/AR049127A1/es unknown
- 2005-05-27 TW TW094117334A patent/TWI363625B/zh not_active IP Right Cessation
2006
- 2006-11-27 ZA ZA200609899A patent/ZA200609899B/xx unknown
- 2006-11-27 IL IL179630A patent/IL179630A/en active IP Right Grant
- 2006-12-28 NO NO20066041A patent/NO338624B1/no unknown
2008
- 2008-07-02 CY CY20081100696T patent/CY1110388T1/el unknown
2009
- 2009-10-20 CL CL2009001980A patent/CL2009001980A1/es unknown
2010
- 2010-03-08 US US12/719,221 patent/US20100168133A1/en not_active Abandoned
2012
- 2012-07-06 JP JP2012152373A patent/JP5675718B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CN102908347A (zh)	2013-02-06
KR101371653B1 (ko)	2014-03-07
HK1106136A1 (en)	2008-03-07
AU2005249231B2 (en)	2010-11-11
ZA200609899B (en)	2009-01-28
CN1976704B (zh)	2012-12-05
NO338624B1 (no)	2016-09-19
DE602005005810D1 (de)	2008-05-15
KR20130024969A (ko)	2013-03-08
AR049127A1 (es)	2006-06-28
CY1110388T1 (el)	2015-04-29
KR20070017393A (ko)	2007-02-09
BRPI0510414B1 (pt)	2022-04-05
EP1753427A1 (en)	2007-02-21
CN1976704A (zh)	2007-06-06
CA2566544A1 (en)	2005-12-15
NZ550840A (en)	2010-01-29
BRPI0510414A (pt)	2007-10-23
AP2006003828A0 (en)	2006-12-31
PT1753427E (pt)	2008-07-04
EP1753427B1 (en)	2008-04-02
DK1753427T3 (da)	2008-07-21
HRP20080307T3 (hr)	2008-07-31
RS50585B (sr)	2010-05-07
WO2005117875A1 (en)	2005-12-15
PA8635201A1 (es)	2006-05-16
US20070249667A1 (en)	2007-10-25
TWI363625B (en)	2012-05-11
JP2008500992A (ja)	2008-01-17
TW200608974A (en)	2006-03-16
ME01105B (me)	2013-03-20
US20100168133A1 (en)	2010-07-01
MY140611A (en)	2009-12-31
CL2009001980A1 (es)	2010-04-16
CA2566544C (en)	2012-04-17
JO2524B1 (en)	2010-03-17
JP5081617B2 (ja)	2012-11-28
AU2005249231A1 (en)	2005-12-15
ES2306146T3 (es)	2008-11-01
IL179630A (en)	2011-05-31
EA200602260A1 (ru)	2007-04-27
EA010651B1 (ru)	2008-10-30
UA90267C2 (ru)	2010-04-26
ATE390925T1 (de)	2008-04-15
SI1753427T1 (sl)	2008-10-31
AP2037A (en)	2009-10-09
MXPA06013888A (es)	2007-01-26
DE602005005810T2 (de)	2009-04-09
JP2012229239A (ja)	2012-11-22
NO20066041L (no)	2007-02-27
JP5675718B2 (ja)	2015-02-25
IL179630A0 (en)	2007-07-04

Publication	Publication Date	Title
AP2037A (en)	2009-10-09	Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
HUE050998T2 (hu)	2021-01-28	Gyógyszerek fibrotikus betegségek kezelésére
PL1888548T3 (pl)	2013-01-31	Pochodna chinoliny do leczenia schorzeń siatkówki
HUS1500058I1 (hu)	2016-01-28	Benzoxazint tartalmazó gyógyszer-kombináció légúti betegségek kezelésére
GB0312832D0 (en)	2003-07-09	2-amino-pyridine derivatives useful for the treatment of diseases
IL184123A0 (en)	2008-12-29	Quinoline derivatives for the treatment of latent tuberculosis
IL184934A0 (en)	2007-12-03	4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases
IL176629A0 (en)	2006-10-31	Sulfonamide derivatives for the treatment of diseases
AP2006003669A0 (en)	2006-06-30	Sulfonamide derivatives for the treatment of diseases
IL184124A0 (en)	2007-10-31	Medicaments for the treatment or prevention of fibrotic diseases
ZA200705160B (en)	2008-09-25	Quinoline derivatives for the treatment of latent tuberculosis
GB0428218D0 (en)	2005-01-26	Medicament for Treatment of Inflammatory Diseases
ZA200606780B (en)	2008-08-27	Compounds for the treatment of diseases
GB0425054D0 (en)	2004-12-15	Formamide derivatives for the treatment of diseases
GB0408297D0 (en)	2004-05-19	Indole derivatives for the treatment of diseases
GB0312842D0 (en)	2003-07-09	2-amino-pyridine derivatives useful for the treatment of diseases
GB0312840D0 (en)	2003-07-09	2-amino-pyridine derivatives useful for the treatment of diseases
IL176564A0 (en)	2006-10-31	Sulfonamide derivatives for the treatment of diseases
GB0406387D0 (en)	2004-04-21	Sulfonamide derivatives for the treatment of diseases
GB0406388D0 (en)	2004-04-21	Sulfonamide derivatives for the treatment of diseases
GB0420867D0 (en)	2004-10-20	Compounds for the treatment of diseases
GB0425073D0 (en)	2004-12-15	Compounds for the treatment of diseases
IL177531A0 (en)	2006-12-10	Compounds for the treatment of diseases
AP2006003743A0 (en)	2006-10-31	Compounds useful for the treatment of diseases
GB0425064D0 (en)	2004-12-15	Compounds useful for the treatment of diseases